Science Explorer Back to mapMap
Discussion
Company · Stockholm · Sweden

Karo Pharma (Sweden)

World rank, all time
#30,706
of 34,923
Rank in Sweden
#234
of 259
Research works
143
▲ 200% vs 2018-21
Citations
10k
73.1 per fractional work
Top-10% rate
8.2%
all institutions 10.0%
vs its own fields
1.16×
1.00× is exactly expected
Open access
40%
world 40%
International
32%
world 18%

Which fields of science does Karo Pharma (Sweden) work in?

In all years, 45% of research at Karo Pharma (Sweden) is in Life Sciences, 39% in Health Sciences. Its largest fields are Medicine (37%), Biochemistry, Genetics and Molecular Biology (37%), Chemistry (7%). It does 2.7× the world's share of Life Sciences.

Life Sciences: 64 fractional works · 44.7% of its workBiochemistry, Genetics and Molecular Biology: 52 fractional works · 36.7% of its workMolecular Biology: 27 fractional works · 18.7% of its workGenetics: 23 fractional works · 16.0% of its workCancer Research: 1 fractional works · 0.9% of its workBiotechnology: 1 fractional works · 0.5% of its workCell Biology: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 4 fractional works · 2.8% of its workToxicology: 2 fractional works · 1.5% of its workPharmacology: 2 fractional works · 1.3% of its workNeuroscience: 3 fractional works · 2.4% of its workCellular and Molecular Neuroscience: 2 fractional works · 1.5% of its workBehavioral Neuroscience: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 3 fractional works · 2.0% of its workImmunology: 3 fractional works · 1.8% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.8% of its workPlant Science: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Sciences: 55 fractional works · 38.9% of its workMedicine: 53 fractional works · 36.9% of its workEndocrinology, Diabetes and Metabolism: 18 fractional works · 12.5% of its workOncology: 10 fractional works · 6.8% of its workSurgery: 7 fractional works · 4.9% of its workPharmacology: 3 fractional works · 2.2% of its workPulmonary and Respiratory Medicine: 2 fractional works · 1.7% of its workPhysiology: 2 fractional works · 1.4% of its workEpidemiology: 1 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.0% of its workPathology and Forensic Medicine: 1 fractional works · 0.8% of its workHematology: 1 fractional works · 0.8% of its workDermatology: 1 fractional works · 0.5% of its workNephrology: 1 fractional works · 0.5% of its workOrthopedics and Sports Medicine: 1 fractional works · 0.5% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.2% of its workUrology: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 1.1% of its workNursing: 1 fractional works · 1.0% of its workNutrition and Dietetics: 1 fractional works · 1.0% of its workHealth Professions: 1 fractional works · 0.7% of its workGeneral Health Professions: 1 fractional works · 0.5% of its workPharmacy: 0 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.2% of its workPeriodontics: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.0% of its workPhysical Sciences: 18 fractional works · 12.9% of its workChemistry: 10 fractional works · 6.7% of its workOrganic Chemistry: 4 fractional works · 3.0% of its workSpectroscopy: 3 fractional works · 2.3% of its workAnalytical Chemistry: 1 fractional works · 0.9% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 3 fractional works · 2.4% of its workComputational Theory and Mathematics: 3 fractional works · 2.4% of its workEnvironmental Science: 2 fractional works · 1.7% of its workHealth, Toxicology and Mutagenesis: 1 fractional works · 0.7% of its workEcology: 1 fractional works · 0.5% of its workNature and Landscape Conservation: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemical Engineering: 1 fractional works · 0.6% of its workFiltration and Separation: 1 fractional works · 0.6% of its workEngineering: 1 fractional works · 0.5% of its workControl and Systems Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 0.5% of its workBiomaterials: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.4% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 5 fractional works · 3.5% of its workPsychology: 3 fractional works · 2.0% of its workClinical Psychology: 2 fractional works · 1.2% of its workApplied Psychology: 1 fractional works · 0.5% of its workSocial Psychology: 0 fractional works · 0.3% of its workSocial Sciences: 2 fractional works · 1.2% of its workEducation: 1 fractional works · 0.7% of its workPolitical Science and International Relations: 0 fractional works · 0.2% of its workSociology and Political Science: 0 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.4% of its workArcheology: 0 fractional works · 0.4% of its workALL ITS WORKKaro Pharma(Sweden)143fractional works, all years
Life Sciences45%Physical Sciences13%Health Sciences39%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology5236.7%
    2. Pharmacology, Toxicology and Pharmaceutics42.8%
    3. Neuroscience32.4%
    4. Immunology and Microbiology32.0%
    5. Agricultural and Biological Sciences10.8%
    1. Medicine5336.9%
    2. Nursing11.0%
    3. Health Professions10.7%
    4. Dentistry00.2%
    5. Veterinary00.0%
    1. Chemistry106.7%
    2. Computer Science32.4%
    3. Environmental Science21.7%
    4. Chemical Engineering10.6%
    5. Engineering10.5%
    6. Materials Science10.5%
    7. Physics and Astronomy00.4%
    8. Earth and Planetary Sciences00.1%
    1. Psychology32.0%
    2. Social Sciences21.2%
    3. Arts and Humanities00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 3.20× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.28× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 4.54× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 21.59× its world share, 0 worksPharmacology, Toxico…Chemistry: 3.88× its world share, 0 worksChemistryComputer Science: 0.39× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 1.16× its world share, 0 worksEarth and Planetary …Environmental Science: 1.96× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.69× its world share, 0 worksHealth ProfessionsMedicine: 0.45× its world share, 0 worksMedicinePsychology: 0.60× its world share, 0 worksPsychologySocial Sciences: 2.17× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 21.6×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics21.59×0 works
  2. Immunology and Microbiology4.54×0 works
  3. Chemistry3.88×0 works
  4. Agricultural and Biological Sciences3.20×1 works
  5. Biochemistry, Genetics and Molecular Biology2.28×0 works
  6. Social Sciences2.17×1 works
  7. Environmental Science1.96×0 works
  8. Earth and Planetary Sciences1.16×0 works
  9. Health Professions0.69×0 works
  10. Psychology0.60×0 works
  11. Medicine0.45×0 works
  12. Computer Science0.39×0 works

Who are the top researchers at Karo Pharma (Sweden)?

Ranked on the quality score, Stefan V. Nilsson, Konrad F. Koehler and Elaine M. Quinet lead among researchers whose main affiliation is Karo Pharma (Sweden).

  1. 1 Stefan V. Nilsson Sweden · #828,453 worldwide 13k citations · 61 works
  2. 2 Konrad F. Koehler Sweden · #850,093 worldwide 2.6k citations · 72 works
  3. 3 Elaine M. Quinet Sweden · #914,674 worldwide 2.8k citations · 43 works
  4. 4 Karin Mellström Sweden · #997,659 worldwide 2k citations · 35 works
  5. 5 Mathias Färnegårdh Sweden · #1,844,366 worldwide 1.6k citations · 28 works
  6. 6 Bo Carlsson Sweden · #1,892,811 worldwide 9.9k citations · 19 works
  7. 7 Jan Gustaf Ljunggren Sweden · #1,992,569 worldwide 862 citations · 18 works
  8. 8 Johan Malm Sweden · #2,402,274 worldwide 1.2k citations · 33 works
  9. 9 Anita R. Halpern Sweden · #2,497,553 worldwide 572 citations · 18 works
  10. 10 Lars Öhman Sweden · #2,727,622 worldwide 4.3k citations · 18 works
All ranked researchers at Karo Pharma (Sweden)

What are the most cited papers from Karo Pharma (Sweden)?

The most cited paper from Karo Pharma (Sweden) is "Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β" (George G. J. M. Kuiper, Bo Carlsson, Kaj Grandien et al., 1997), with 4,457 citations. Next come "Molecular basis of agonism and antagonism in the oestrogen receptor" (3,370) and "Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites" (1,865).

Most cited papers
#PaperReleasedCitations
1 Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β George G. J. M. Kuiper, Bo Carlsson, Kaj Grandien et al. · Endocrinology Mar 1997 4,457
2 Molecular basis of agonism and antagonism in the oestrogen receptor Andrzej Marek Brzozowski, Ashley C. W. Pike, Zbigniew Dauter et al. · Nature Oct 1997 3,370
3 Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites Kolja Paech, Paul M. Webb, George G. J. M. Kuiper et al. · Science 5 Sep 1997 1,865
4 Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist Ashley C. W. Pike, Andrzej M. Brzozowski, Roderick E. Hubbard et al. · The EMBO Journal Open access Sep 1999 981
5 Differential Response of Estrogen Receptor α and Estrogen Receptor β to Partial Estrogen Agonists/Antagonists Tomas Barkhem, Bo Carlsson, Yvonne Nilsson et al. · Molecular Pharmacology Jul 1998 779
All 60 most cited papers, with filters and sorting

Which keywords describe research at Karo Pharma (Sweden)?

By fractional works in all years, weighted toward what it does more of than the world: Nuclear Receptors, Breast Cancer, Transcriptional Regulation, Estrogen, Signaling, G Protein-Coupled Receptor, Glucocorticoids and Receptor.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Nuclear Receptors32▲ 123×5 topics
  2. Breast Cancer26▲ 64×5 topics
  3. Transcriptional Regulation24▲ 67×5 topics
  4. Estrogen23▲ 211×2 topics
  5. Signaling22▲ 132×3 topics
  6. G Protein-Coupled Receptor20▲ 215×2 topics
  7. Glucocorticoids20▲ 252×1 topic
  8. Receptor20▲ 197×1 topic
  9. Inflammation12▲ 3.5×23 topics
  10. Cancer11▲ 5.5×16 topics
  11. Metabolism11▲ 12×12 topics
  12. Cardiovascular Risk10▲ 20×3 topics
  13. Pregnancy7▲ 23×4 topics
  14. Neurodevelopment6▲ 60×2 topics
  15. Thyroid Dysfunction6▲ 108×1 topic
  16. Thyroid Hormone6▲ 108×1 topic
  17. Cell Signaling6▲ 12×5 topics
  18. Metabolic Syndrome6▲ 4.6×4 topics
  19. Acute Promyelocytic Leukemia5▲ 125×1 topic
  20. Retinoic Acid5▲ 125×1 topic
  21. Depression5▲ 4.7×6 topics
  22. Pharmacology5▲ 10×4 topics
  23. Pharmacokinetics5▲ 12×3 topics
  24. Atherosclerosis4▲ 8.7×5 topics
  25. Metabolic Regulation4▲ 11×3 topics
  26. Medicinal Chemistry4▲ 8.0×6 topics
  27. ATP-dependent Transporters4▲ 56×1 topic
  28. Glycosylation4▲ 13×3 topics
  29. Multidrug Resistance4▲ 49×1 topic
  30. Cholesterol4▲ 16×3 topics
  31. Hypertension4▲ 8.2×4 topics
  32. Cardiovascular Events4▲ 17×2 topics
  33. Monoclonal Antibody4▲ 40×2 topics
  34. Biopharmaceutical Production4▲ 35×2 topics
  35. Macrophage4▲ 48×2 topics
  36. Hormone Therapy4▲ 25×3 topics
  37. Aldosterone4▲ 58×1 topic
  38. LXR4▲ 122×1 topic
  39. Primary Aldosteronism4▲ 58×1 topic
  40. SREBP4▲ 122×1 topic

Which research topics does Karo Pharma (Sweden) publish most on?

By volume in 2022-now: Education and Character Development, Pancasila Values in Education, Educational Curriculum and Learning Methods and Plant Pathogens and Resistance.

  1. 1 Education and Character Development Education 0 works
  2. 2 Pancasila Values in Education Education 0 works
  3. 3 Educational Curriculum and Learning Methods Education 0 works
  4. 4 Plant Pathogens and Resistance Plant Science 0 works
  5. 5 Marine animal studies overview Ecology 0 works
  6. 6 Pharmacological Effects of Natural Compounds Pharmacology 0 works
  7. 7 Retinoids in leukemia and cellular processes Molecular Biology 0 works
  8. 8 Psoriasis: Treatment and Pathogenesis Immunology 0 works
  9. 9 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  10. 10 Cephalopods and Marine Biology Ecology, Evolution, Behavior and Systematics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.0%not open60.0%

World: 40% of research is openly available.

with international co-authors32.0%domestic only68.0%

World: 18% is written across borders.

How has Karo Pharma (Sweden)'s research output changed?

Output in 2022-2025 was 200% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Karo Pharma (Sweden) as a percentage of every work published that year, 0.0000093% in 2023.

still counting0.00050%0.0010%Karo Pharma (Sweden)0.000035% in 202519801990200020102020

Fractional works of Karo Pharma (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Stockholm

All research institutions in Stockholm

Share Karo Pharma (Sweden)'s ranking

Karo Pharma (Sweden) on Science Explorer

A card with Karo Pharma (Sweden)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Karo Pharma (Sweden). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.